2004 OPPS and physician fee proposed rules
This article was originally published in The Gray Sheet
CMS anticipates releasing the outpatient proposed rule "earlier this year than last year" to allow more time to develop the final version after comments are received, Hospital & Ambulatory Policy Group Director Liz Richter states at MDMA's recent annual meeting in Washington, D.C. The 2003 OPPS proposed rule was released Aug. 9, 2002. The 2004 physician fee proposed rule, meanwhile, "will be out well ahead of outpatient - end of June, beginning of July," Richter reports...
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.